New User:

Forgot your password?

Stock Market & Financial Investment News

News For ACTC From The Last 14 Days
Check below for free stories on ACTC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 10, 2014
12:14 EDTACTCSEC announces fraud charges against Advanced Cell Tech, former CEO
The Securities and Exchange Commission has charged a Massachusetts-based biotech company and its former CEO with defrauding investors by failing to report his sales of company stock.The federal securities laws require certain corporate executives to report their transactions in the companyís stock in order to give investors the opportunity to evaluate whether the purchases and sales by an insider could be indicative of the prospects of the company. An SEC investigation found that after Gary H. Rabin became CEO, CFO, and chairman of Advanced Cell Technology in 2010, he repeatedly failed to report his sales of company stock for the next few years. Subsequently, ACTís annual reports and proxy statements during that period were inaccurate because they failed to report that Rabin was not complying with his obligation to disclose his substantial sales of ACT stock. ACT and Rabin agreed to settle the SECís charges.
September 5, 2014
09:17 EDTACTCAdvanced Cell Technology issued new patent from USPTO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use